Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics
Circulating levels of calcium ion (Ca2+) are maintained within a narrow physiological range mainly by the action of parathyroid hormone (PTH) secreted from parathyroid cells. Parathyroid cells can sense small fluctuations in plasma Ca2+ levels by virtue of a cell surface Ca2+ receptor (CaR) that bel...
Saved in:
Main Authors: | Nobuo Nagano (Author), Edward F. Nemeth (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2005-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
by: Fizza Abbas, et al.
Published: (2019) -
Refractory tertiary hyperparathyroidism after calcimimetics and delayed parathyroidectomy in a kidney transplant recipient
by: Ekamol Tantisattamo, et al.
Published: (2012) -
Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: Role of Calcium/Calmodulin-Dependent Protein Kinases in Ischemic Neuronal Death
by: Shigetoshi Yano, et al.
Published: (2005) -
CALCIUM REQUIREMENT AFTER PARATHYROIDECTOMY (PTX) IN SECONDARY HYPERPARATHYROIDISM (2° HPT)
by: YJ Kwon, et al.
Published: (2012) -
Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: Desensitization of N-Methyl-D-aspartate Receptor Channels
by: Noritaka Nakamichi, et al.
Published: (2005)